ALHC Alignment Healthcare, Inc.

Overview and Growth

Fiscal 2025 results for Alignment Healthcare, Inc. combined $3.95B of revenue with net loss of $724.00K and an operating cash inflow of $139.93M. Revenue of $3.95B sets the scale for evaluating how effectively sales translated into profit and cash during the year. Compared with $2.70B in fiscal 2024, revenue recorded a 46.1% year-over-year increase. On a per-share basis, diluted EPS was $0.00, which connects the reported earnings outcome with the company’s diluted share count. At period end, total assets were $1.07B, framing the scale of the company’s operating and financing commitments. Asset turnover was 3.7x, relating the company’s annual revenue directly to the total assets reported at the period end.

Profitability

Operating income was $14.75M, the earnings remaining from reported operations after the company’s recognized operating cost structure. Relative to revenue, operating income represented 0.4%, showing how efficiently sales converted into operating profit. The company ended the period with a net loss of $724.00K, extending the operating result through all remaining items. The net loss equaled 0.0% of revenue, showing the bottom-line deficit relative to the company’s sales base. The pretax result was a loss of $958.00K, establishing the deficit before tax effects. The pretax loss equaled 0.0% of revenue, measuring the pre-tax deficit against sales. The reported income-tax provision was $20.00K, the amount recognized between pretax income and the final net-income result. The loss-to-equity relationship was 0.4%, placing the bottom-line deficit against shareholder capital. The net loss equaled 0.1% of period-end assets, showing the deficit relative to the asset base. The bottom-line deficit decreased from $128.03M in fiscal 2024 to $724.00K.

Liquidity and Capital Structure

At period end, the $1.07B asset base was financed through $886.51M of liabilities and $179.28M of equity. Current assets were $951.58M against $556.87M of current liabilities, framing the resources and obligations classified within the near-term balance-sheet horizon. Current assets covered current liabilities by 1.71x, leaving a positive buffer for near-term obligations. Cash and equivalents totaled $575.82M, identifying the most liquid reported component available within the broader current-asset balance. The cash balance equaled 103.4% of current liabilities, showing how much near-term coverage came from cash alone. Total debt was $323.18M, establishing the amount of borrowing carried within the company’s capital structure. Against book equity, debt measured 1.8x, placing the company’s financial leverage in clear balance-sheet terms. The debt-to-assets relationship was 30.3%, comparing borrowing with the total asset balance. Liabilities represented 83.2% of total assets, quantifying the liability-funded share of the company’s resource base. Measured against total assets, cash and equivalents represented 54.0%, a balance-sheet composition measure rather than a liquidity forecast. Total assets were 36.3% higher than fiscal 2024 assets of $782.06M, measuring the company’s own balance-sheet change. Book equity was 77.6% higher than fiscal 2024 equity of $100.95M, showing how shareholder capital changed year over year. Compared with $432.86M in fiscal 2024, the current cash balance moved 33.0% and finished higher.

Cash Flow and Earnings Quality

The company reported $139.93M of operating cash flow, a cash inflow that shows the cash generated by operations. Capital spending was $26.78M, absorbing part of the cash generated from operations before free cash flow. Capital spending absorbed 19.1% of operating cash flow, quantifying the share of cash from operations directed to investment. The combination of operating cash flow and capital spending produced $113.15M of positive free cash flow for the period. Relative to revenue, free cash flow equaled 2.9%, showing how much sales converted into cash after investment. Measured against total assets, free cash flow represented 10.6%, showing the cash productivity of the company’s assets.

Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated Oct 21, 2026.